When was TARA Biosystems founded?

TARA Biosystems was founded in 2014 and raised its 1st funding round 1 year after it was founded.

Where is TARA Biosystems located?

TARA Biosystems is headquartered in New York City, United States. It is registered at CORPORATION TRUST CENTER 1209 ORANGE ST.

How many employees does TARA Biosystems have?

As of Dec 31, 2022, TARA Biosystems has 11 employees, reflecting a 58% year-over-year growth in headcount.

Is TARA Biosystems a funded company?

TARA Biosystems is a funded company, having raised a total of $21.3M across 3 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Dec 15, 2015.

When was the latest funding round of TARA Biosystems?

TARA Biosystems' latest funding was a $***** Series A round on Jun 23, 2020, with participation from 9 investors. Its primary sector is Life Sciences Platforms and Tools. In United States, the Life Sciences Platforms and Tools sector has seen $1.23B in funding in 2026 to date.

Where does TARA Biosystems rank among its competitors?

TARA Biosystems ranks 45th amongst 1969 active competitors, of which 449 are funded. It stands 10th in terms of total funding among its competitors. The most recent competitor to raise funding was LifeMine Therapeutics, which secured $75M in Aug, 2026.

Who are the top competitors of TARA Biosystems?

TARA Biosystems' top competitors include Antheia, Transcenta and Akeso. Among them, LifeMine Therapeutics secured the most recent funding round in August, 2026.

TARA Biosystems - 2026 Company Profile, Team, Funding & Competitors

Company Details

AI-driven platform transforming drug discovery and development for better patient outcomes. The company harnesses high-quality patient data and powerful Artificial Intelligence-driven technology to accelerate the creation of life-changing medicines. Through its Opal Computational Platform, it combines machine learning, tissue biology, and patient data to create a suite of powerful capabilities that bring the future of drug discovery and development to bear. It is a new kind of company, made possible by advances in technology and patient data and dedicated to advancing their combined power. The company is focused on innovating drug discovery and development in pursuit of better health outcomes for patients everywhere.

Website: tarabiosystems.com
Social
Email ID: *****@tarabiosystems.com
Registered Address: CORPORATION TRUST CENTER 1209 ORANGE ST

Key Metrics

Founded Year

2014

Location

New York City, United States

Stage

Acquired

Total Funding

$21.3M in 3 rounds

Latest Funding Round

Series A, Jun 23, 2020, $*****

Investors

Partnership for New York City & 15 more

Ranked

45^th among 1969 active competitors

Employee Count

11 as on Dec 31, 2022

Similar Companies

Antheia & 2676 more

Exit Details

Acquired by Valo Health (Mar 01, 2022)

View TARA Biosystems' full profile

TARA Biosystems is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
TARA BIOSYSTEMS INC CIN: 471250439 , United States, Active	Dec 31, 1999	-	11 (As on Dec 31, 2018)	-

TARA Biosystems got acquired by Valo Health on Mar 01, 2022.

Click here to take a look at TARA Biosystems's acquisition in detail

TARA Biosystems has raised a total funding of $21.3M over 3 rounds. Its first funding round was on Dec 15, 2015. Its latest funding round was a Series A round on Jun 23, 2020 for $*****. 9 investors participated in its latest round. TARA Biosystems has 16 institutional investors.

Here is the list of recent funding rounds of TARA Biosystems:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 23, 2020	6035282	Series A	4968006	3970736	6811099	9948977
Oct 16, 2017	3840101	Series A	2165317	4653237	1134780	ESD & 3 more
Dec 15, 2015	6158496	Seed	3711546	9388745	Partnership for New York City & 1 more	3631255

Access funding benchmarks and valuations. Sign up today!

View details of TARA Biosystems's funding rounds and investors

The founders of TARA Biosystems are Milica Radisic, Boyang Zhang, Yimu Zhao and Kacey Ronaldson Bouchard.

Here are the details of TARA Biosystems' key team members:

Milica Radisic: Co-Founder of TARA Biosystems and founder of 1 other company.
Contact Info: 1 email address
Boyang Zhang: Former Co-Founder of TARA Biosystems.
Yimu Zhao: Co-Founder of TARA Biosystems.
Kacey Ronaldson Bouchard: Co-Founder of TARA Biosystems.

View details of TARA Biosystems's Founder profiles and Board Members

TARA Biosystems' employee count trend

TARA Biosystems has 11 employees as of Dec 22. The total employee count is 57.0% more than what it was in Dec 21. Here is TARA Biosystems's employee count trend over the years:

Employee count trend for TARA Biosystems

Uncover TARA Biosystems' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of TARA Biosystems include Antheia, Transcenta and Akeso. Here is the list of Top 10 competitors of TARA Biosystems, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Antheia 2013, Palo Alto (United States), Series C	Genetically engineered yeast cells to produce medicinal products	$176M	Viking Global Investors, ATHOS KG & 15 others	67/100
2nd	Transcenta 2019, Suzhou (China), Public	Developer of antibody-based therapeutics	$205M	Lilly Asia Ventures, Temasek & 11 others	66/100
3rd	Akeso 2012, Zhongshan (China), Public	Developer of antibody drug conjugates for the treatment of broad spectrum diseases	$195M	Loayal Valley Capital, Sino Biopharmaceutical ... & 18 others	65/100
4th	Korro Bio 2018, Cambridge (United States), Public	Provider of RNA editing technologies to develop genetic medicines for rare and prevalent diseases	$4M	Cormorant Asset Management, Atlas Venture ... & 14 others	64/100
5th	Novogene Corporation 2011, Beijing (China), Series B	Provider of genomic services and solutions	$75M	SDIC Innovation, CMB International Capital ... & 4 others	64/100
6th	Fermentalg 2005, Libourne (France), Public	Innovating with algae for sustainable solutions in nutrition and environmental impact	$30.3M	Demeter, Smalt Capital & 14 others	63/100
7th	Microban 1994, Huntersville (United States), Acquired	Antimicrobial and odor control technologies for durable product protection and freshness	$64.6M	TA Associates, UBS & 1 others	63/100
8th	LifeMine Therapeutics 2016, Watertown (United States), Series E	Developer of novel drugs from fungi via genome mining and recombinant overexpression	$563M	Fidelity Investments, 6 Dimensions Capital ... & 17 others	63/100
9th	Dewpoint Therapeutics 2018, Boston (United States), Series D	Developer of small molecule based therapeutics	$364M	Maverick Ventures, SoftBank Vision Fund & 16 others	62/100
10th	One Biosciences 2020, Paris (France), Series A	Developer of single-cell therapeutics solutions to treat multiple health disorders	$22.4M	BLAST Premier, Redmile Group & 6 others	62/100
45th	TARA Biosystems 2014, New York City (United States), Acquired	AI-driven platform transforming drug discovery and development for better patient outcomes	$21.3M	Acks, Korys & 14 others	56/100